| Item | Current | Prior | YoY % |
|---|---|---|---|
| Net Sales | ¥16.67B | ¥16.16B | +3.1% |
| Cost of Sales | ¥13.51B | ¥13.11B | +3.1% |
| Gross Profit | ¥3.15B | ¥3.06B | +3.2% |
| SG&A Expenses | ¥1.71B | ¥1.63B | +4.3% |
| Operating Income | ¥1.45B | ¥1.42B | +1.8% |
| Non-operating Income | ¥174M | ¥135M | +28.9% |
| Non-operating Expenses | ¥53M | ¥51M | +3.9% |
| Ordinary Income | ¥1.57B | ¥1.50B | +4.3% |
| Profit Before Tax | ¥2.17B | ¥1.53B | +42.5% |
| Income Tax Expense | ¥658M | ¥471M | +39.7% |
| Net Income | ¥1.52B | ¥1.05B | +43.7% |
| Net Income Attributable to Owners | ¥1.52B | ¥1.05B | +43.7% |
| Total Comprehensive Income | ¥1.97B | ¥900M | +118.7% |
| Depreciation & Amortization | ¥289M | ¥284M | +1.8% |
| Interest Expense | ¥50M | ¥43M | +16.3% |
| Basic EPS | ¥55.21 | ¥38.53 | +43.3% |
| Dividend Per Share | ¥0.00 | ¥0.00 | - |
| Item | Current End | Prior End | Change |
|---|---|---|---|
| Current Assets | ¥10.83B | ¥9.76B | +¥1.07B |
| Cash and Deposits | ¥3.95B | ¥3.31B | +¥634M |
| Accounts Receivable | ¥2.00B | ¥2.06B | ¥-59M |
| Inventories | ¥1.31B | ¥1.38B | ¥-74M |
| Non-current Assets | ¥19.71B | ¥19.65B | +¥59M |
| Item | Current | Prior | Change |
|---|---|---|---|
| Operating Cash Flow | ¥1.02B | ¥2.00B | ¥-985M |
| Investing Cash Flow | ¥869M | ¥-372M | +¥1.24B |
| Financing Cash Flow | ¥-1.25B | ¥-1.15B | ¥-106M |
| Free Cash Flow | ¥1.89B | - | - |
| Item | Value |
|---|---|
| Net Profit Margin | 9.1% |
| Gross Profit Margin | 18.9% |
| Current Ratio | 137.2% |
| Quick Ratio | 120.6% |
| Debt-to-Equity Ratio | 0.68x |
| Interest Coverage Ratio | 28.96x |
| EBITDA Margin | 10.4% |
| Effective Tax Rate | 30.3% |
| Item | YoY Change |
|---|---|
| Net Sales YoY Change | +3.1% |
| Operating Income YoY Change | +1.9% |
| Ordinary Income YoY Change | +4.3% |
| Net Income Attributable to Owners YoY Change | +43.7% |
| Total Comprehensive Income YoY Change | +118.5% |
| Item | Value |
|---|---|
| Shares Outstanding (incl. Treasury) | 35.00M shares |
| Treasury Stock | 7.48M shares |
| Average Shares Outstanding | 27.47M shares |
| Book Value Per Share | ¥661.38 |
| EBITDA | ¥1.74B |
| Item | Amount |
|---|---|
| Q2 Dividend | ¥0.00 |
| Year-End Dividend | ¥15.00 |
| Segment | Revenue | Operating Income |
|---|---|---|
| Biotechnology | ¥847M | ¥160M |
| Sugar | ¥15.83B | ¥1.97B |
| Item | Forecast |
|---|---|
| Net Sales Forecast | ¥32.20B |
| Operating Income Forecast | ¥2.50B |
| Ordinary Income Forecast | ¥2.80B |
| Net Income Attributable to Owners Forecast | ¥2.40B |
| Basic EPS Forecast | ¥87.53 |
| Dividend Per Share Forecast | ¥15.00 |
| Property, Plant & Equipment | ¥9.43B | ¥9.41B | +¥25M |
| Intangible Assets | ¥16M | ¥18M | ¥-2M |
| Investment Securities | ¥8.30B | ¥8.38B | ¥-72M |
| Total Assets | ¥30.54B | ¥29.41B | +¥1.14B |
| Current Liabilities | ¥7.89B | ¥7.95B | ¥-52M |
| Accounts Payable | ¥1.56B | ¥1.35B | +¥205M |
| Short-term Loans | ¥2.40B | ¥2.70B | ¥-300M |
| Non-current Liabilities | ¥4.44B | ¥4.84B | ¥-398M |
| Long-term Loans | ¥3.26B | ¥3.86B | ¥-604M |
| Total Liabilities | ¥12.34B | ¥12.79B | ¥-450M |
| Total Equity | ¥18.20B | ¥16.62B | +¥1.58B |
| Capital Stock | ¥1.75B | ¥1.75B | ¥0 |
| Capital Surplus | ¥241M | ¥241M | ¥0 |
| Retained Earnings | ¥16.76B | ¥15.66B | +¥1.10B |
| Treasury Stock | ¥-2.86B | ¥-2.89B | +¥29M |
| Owners' Equity | ¥18.20B | ¥16.62B | +¥1.58B |
| Working Capital | ¥2.94B | - | - |